Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Influence of hybrid inorganic/organic mesoporous and nanostructured materials on the cephalosporins' efficacy on different bacterial strains.

Carmen Chifiriuc M, Mihaiescu D, Ilinca E, Marutescu L, Mihaescu G, Mihai Grumezescu A.

IET Nanobiotechnol. 2012 Dec;6(4):156-61. doi: 10.1049/iet-nbt.2011.0066.

PMID:
23101869
2.
3.

In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.

Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V.

J Med Assoc Thai. 2008 Oct;91 Suppl 3:S21-7.

PMID:
19255989
4.

Susceptibility of blood isolates to various antibiotics, in particular to cephalosporins.

Ling J, Chau PY, Leung YK, Ng WS.

J Antimicrob Chemother. 1983 May;11(5):473-80.

PMID:
6874632
5.

Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study.

Azam A, Ahmed AS, Oves M, Khan MS, Habib SS, Memic A.

Int J Nanomedicine. 2012;7:6003-9. doi: 10.2147/IJN.S35347. Epub 2012 Dec 5.

6.
7.

[Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].

Tuchiluş C, Poiată A, Bădicuţ I, Teodor A, Luca V, Grigore L, Buiuc D.

Rev Med Chir Soc Med Nat Iasi. 2003 Jul-Sep;107(3):595-8. Romanian.

PMID:
14756068
8.

In vitro antimicrobial activity of cefotaxime, a new cephalosporin.

Masuyoshi S, Arai S, Miyamoto M, Mitsuhashi S.

Antimicrob Agents Chemother. 1980 Jul;18(1):1-8.

9.

Antibacterial activity of cefepime in vitro.

Liu YC, Huang WK, Cheng DL.

Chemotherapy. 1994;40(6):384-90.

PMID:
7842821
10.

In-vitro activity of cefepime and other antimicrobials: survey of European isolates.

Thornsberry C, Brown SD, Yee YC, Bouchillon SK, Marler JK, Rich T.

J Antimicrob Chemother. 1993 Nov;32 Suppl B:31-53.

PMID:
8150766
11.
12.

A comparative study of the in-vitro activity of cefepime and other cephalosporins.

Lim VK, Halijah MY.

Malays J Pathol. 1993 Jun;15(1):65-8.

PMID:
8277793
13.

Pharmacokinetic and microbial susceptibility studies of ceftriaxone.

Baumgartner JD, Glauser MP.

Eur J Clin Microbiol. 1983 Oct;2(5):501-4.

PMID:
6315426
14.

Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

Lodise TP, Low DE.

Drugs. 2012 Jul 30;72(11):1473-93. doi: 10.2165/11635660-000000000-00000. Review.

PMID:
22779432
15.

[Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].

Chen MJ, Wang H; China Nosocomial Pathogens Resistance Surveillance Study Group.

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):375-81. Chinese.

PMID:
12820912
16.

In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China.

Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M.

J Infect Chemother. 2000 Jun;6(2):81-5.

PMID:
11810540
17.

[Cefepime (maxipime), large spectrum 4th generation cephalosporin, resistant to beta-lactamases].

Angelescu M, Apostol A.

Chirurgia (Bucur). 2001 Nov-Dec;96(6):547-52. Review. Romanian.

PMID:
12731231
18.

The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.

Acred P, Ryan DM, Sowa MA, Watts CM.

J Antimicrob Chemother. 1981 Sep;8 Suppl B:247-55.

PMID:
19802994
19.

[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].

Miwatani T, Takeda Y, Kotera K, Nishimura T, Takashima T, Hiromatsu K, Tabuki K, Fujimoto S, Kamiki T, Yoshizaki E, Yabuuchi E, Shimizu Y, Matsunaga K, Yamanaka K, Furuta I, Iimori M, Kodama J, Tanaka M, Maejima K, Nukina M, Takashima E, Takahashi M, Harikane O, Masutani T.

Jpn J Antibiot. 1983 Feb;36(2):260-76. Japanese.

PMID:
6304368
20.

[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].

Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.

Jpn J Antibiot. 2003 Oct;56(5):458-96. Japanese.

PMID:
14692381
Items per page

Supplemental Content

Write to the Help Desk